The role of peroxiredoxin III in the ototoxic drug-induced mitochondrial apoptosis of cochlear hair cells

Conclusion. Peroxiredoxin (Prx) III plays a protective role in cisplatin- and gentamicin-induced apoptosis via a mitochondria-dependent pathway in cochlear hair cells. Objectives. The aim of the present study was to investigate the effects of the depletion of endogenous Prx III on oxidative damage t...

Full description

Saved in:
Bibliographic Details
Published inActa oto-laryngologica Vol. 128; no. 9; pp. 944 - 951
Main Authors Seok Choi, Ho, Joo Park, Kwang, Chul Hwang, Sung, Yi Park, Hun, Sun Kim, Young, Park, Keehyun
Format Journal Article
LanguageEnglish
Published Stockholm Informa UK Ltd 01.01.2008
Taylor & Francis
Taylor and Francis
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Conclusion. Peroxiredoxin (Prx) III plays a protective role in cisplatin- and gentamicin-induced apoptosis via a mitochondria-dependent pathway in cochlear hair cells. Objectives. The aim of the present study was to investigate the effects of the depletion of endogenous Prx III on oxidative damage to mitochondrial components and on apoptotic events with the use of RNA interference. Materials and methods. Depletion of Prx III was done by RNA interference in cochlear hair cells (UB/OC-1), and cells were exposed to ototoxic drugs (cisplatin or gentamicin). We then compared the apoptotic signaling between Prx III-depleted and control cells. Results. The depletion of Prx III resulted in increased intracellular ROS levels accompanied by enhanced apoptosis by ototoxic drugs. The Prx III-depleted cells showed mitochondrial membrane potential collapse, cytochrome c release, and caspase activation.
AbstractList CONCLUSIONPeroxiredoxin (Prx) III plays a protective role in cisplatin- and gentamicin-induced apoptosis via a mitochondria-dependent pathway in cochlear hair cells.OBJECTIVESThe aim of the present study was to investigate the effects of the depletion of endogenous Prx III on oxidative damage to mitochondrial components and on apoptotic events with the use of RNA interference.MATERIALS AND METHOD. Depletion of Prx III was done by RNA interference in cochlear hair cells (UB/OC-1), and cells were exposed to ototoxic drugs (cisplatin or gentamicin). We then compared the apoptotic signaling between Prx III-depleted and control cells.RESULTSThe depletion of Prx III resulted in increased intracellular ROS levels accompanied by enhanced apoptosis by ototoxic drugs. The Prx III-depleted cells showed mitochondrial membrane potential collapse, cytochrome c release, and caspase activation.
Peroxiredoxin (Prx) III plays a protective role in cisplatin- and gentamicin-induced apoptosis via a mitochondria-dependent pathway in cochlear hair cells. The aim of the present study was to investigate the effects of the depletion of endogenous Prx III on oxidative damage to mitochondrial components and on apoptotic events with the use of RNA interference. . Depletion of Prx III was done by RNA interference in cochlear hair cells (UB/OC-1), and cells were exposed to ototoxic drugs (cisplatin or gentamicin). We then compared the apoptotic signaling between Prx III-depleted and control cells. The depletion of Prx III resulted in increased intracellular ROS levels accompanied by enhanced apoptosis by ototoxic drugs. The Prx III-depleted cells showed mitochondrial membrane potential collapse, cytochrome c release, and caspase activation.
Conclusion. Peroxiredoxin (Prx) III plays a protective role in cisplatin- and gentamicin-induced apoptosis via a mitochondria-dependent pathway in cochlear hair cells. Objectives. The aim of the present study was to investigate the effects of the depletion of endogenous Prx III on oxidative damage to mitochondrial components and on apoptotic events with the use of RNA interference. Materials and methods. Depletion of Prx III was done by RNA interference in cochlear hair cells (UB/OC-1), and cells were exposed to ototoxic drugs (cisplatin or gentamicin). We then compared the apoptotic signaling between Prx III-depleted and control cells. Results. The depletion of Prx III resulted in increased intracellular ROS levels accompanied by enhanced apoptosis by ototoxic drugs. The Prx III-depleted cells showed mitochondrial membrane potential collapse, cytochrome c release, and caspase activation.
Author Yi Park, Hun
Chul Hwang, Sung
Sun Kim, Young
Seok Choi, Ho
Park, Keehyun
Joo Park, Kwang
Author_xml – sequence: 1
  givenname: Ho
  surname: Seok Choi
  fullname: Seok Choi, Ho
  email: parkkh@ajou.ac.kr
  organization: 1Department of Otorhinolaryngology-Head & Neck Surgery, Inha University College of Medicine, Incheon
– sequence: 2
  givenname: Kwang
  surname: Joo Park
  fullname: Joo Park, Kwang
  email: parkkh@ajou.ac.kr
  organization: 1Department of Otorhinolaryngology-Head & Neck Surgery, Inha University College of Medicine, Incheon
– sequence: 3
  givenname: Sung
  surname: Chul Hwang
  fullname: Chul Hwang, Sung
  email: parkkh@ajou.ac.kr
  organization: 1Department of Otorhinolaryngology-Head & Neck Surgery, Inha University College of Medicine, Incheon
– sequence: 4
  givenname: Hun
  surname: Yi Park
  fullname: Yi Park, Hun
  email: parkkh@ajou.ac.kr
  organization: 1Department of Otorhinolaryngology-Head & Neck Surgery, Inha University College of Medicine, Incheon
– sequence: 5
  givenname: Young
  surname: Sun Kim
  fullname: Sun Kim, Young
  email: parkkh@ajou.ac.kr
  organization: 1Department of Otorhinolaryngology-Head & Neck Surgery, Inha University College of Medicine, Incheon
– sequence: 6
  givenname: Keehyun
  surname: Park
  fullname: Park, Keehyun
  email: parkkh@ajou.ac.kr
  organization: 1Department of Otorhinolaryngology-Head & Neck Surgery, Inha University College of Medicine, Incheon
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20597224$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19086304$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1q3TAQhUVJaW6SPkA3RZtm51aSLVmm3ZTQnwuBbpK1kaVxrSBb7simydtH5t62lEKKQDNivjPM6JyRkylOQMgrzt5yptk7xhhXlWY145rJSpXPyI4ryQshJD8hu61eZKA5JWcp3W3PRssX5JQ3TKuSVTvibwagGAPQ2NMZMN57BJfvie73e5rDkoG45HPvLXW4fi_85FYLjo5-iXaIk0NvAjVznJeYfNo62VwIYJAOxiO1EEK6IM97ExK8PMZzcvv5083V1-L625f91cfrwlZKLoW1QqrOAre8c43Vpu_LDrjoc1o1grtSa94JZZzthHNgVVOL2rJSdlXeqivPyeWh74zxxwppaUeftgnMBHFNrWp0XTOl_gsK1kjBKp1BfgAtxpQQ-nZGPxp8aDlrNyPaf4zImtfH5ms3gvujOP58Bt4cAZOsCT2ayfr0mxNM5r3Exn04cH7qI47mZ8Tg2sU8hIi_ROVTc7z_Sz6ACctgDUJ7F1ecshNPbPEI_-e4bw
CODEN AOLAAJ
CitedBy_id crossref_primary_10_1021_pr100963n
crossref_primary_10_3390_ijms12128982
crossref_primary_10_3389_fneur_2021_725566
crossref_primary_10_1002_pmic_201200273
crossref_primary_10_1089_ars_2012_4599
Cites_doi 10.1016/S0165-5876(02)00353-1
10.1006/cbir.1998.0339
10.1074/jbc.M407707200
10.1177/000348948809700107
10.1016/0378-5955(81)90037-X
10.1016/S0161-813X(00)00010-3
10.1073/pnas.91.15.7017
10.1016/0378-5955(94)90255-0
10.1016/S0385-8146(03)00049-X
10.1111/j.1749-6632.1999.tb08633.x
10.1080/15216540252774748
10.1002/neu.10111
10.1001/archotol.1994.01880290051009
10.1016/j.freeradbiomed.2005.02.026
10.1016/S0968-0004(02)00003-8
10.1083/jcb.200607061
10.3109/08860229309046144
10.1016/0378-5955(96)00075-5
10.1158/0008-5472.CAN-04-1581
10.1097/00005537-200107000-00005
ContentType Journal Article
Copyright 2008 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2008
2008 INIST-CNRS
Copyright_xml – notice: 2008 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2008
– notice: 2008 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
7X8
8BM
DOI 10.1080/00016480701805463
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Neurosciences Abstracts
MEDLINE - Academic
ComDisDome
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Neurosciences Abstracts
ComDisDome
MEDLINE - Academic
DatabaseTitleList ComDisDome
MEDLINE


Neurosciences Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1651-2251
EndPage 951
ExternalDocumentID 10_1080_00016480701805463
19086304
20597224
280600
Genre Original Article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--Z
.55
.GJ
00X
03L
04C
0BK
0R~
23M
34G
36B
39C
3O-
4.4
53G
5GY
5RE
5VS
6PF
85S
AAJNR
AALIY
AALUX
AAPUL
AAPXX
AAQRR
AAWTL
ABBKH
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLJU
ABLKL
ABTAH
ABUPF
ABWCV
ABXYU
ABZEW
ACENM
ACFUF
ACGEJ
ACGFS
ACKZS
ACLSK
ADBBV
ADCVX
ADFCX
ADFOM
ADFZZ
ADRBQ
ADXPE
AECIN
AEIIZ
AENEX
AEOZL
AEYQI
AFFNX
AFFVI
AFKVX
AFLEI
AFOSN
AFWLO
AGDLA
AGFJD
AGRBW
AGYJP
AHPSJ
AIJEM
AIRBT
AJVHN
AJWEG
AKBVH
ALIIL
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMDAE
AWYRJ
BABNJ
BLEHA
BMSDO
BOHLJ
BRMBE
CAG
CCCUG
COF
CS3
CYYVM
CZDIS
DKSSO
DRXRE
DWTOO
EAP
EBB
EBC
EBD
EBS
EBX
ECF
ECT
ECV
EHN
EIHBH
EJD
EMB
EMK
EMOBN
ENC
ENX
EPL
EPS
EPT
ESX
F5P
FEDTE
HVGLF
HZ~
J5H
JENTW
KRBQP
KSSTO
KWAYT
KYCEM
L7B
LJTGL
M44
M4Z
O9-
OHT
OVD
P2P
QQXMO
Q~Q
RNANH
RVRKI
S70
SV3
TEORI
TFDNU
TFL
TFW
TN5
TUS
UEQFS
V1S
WH7
WQ9
X7M
ZCG
ZGI
ZY4
~1N
AAMIU
AAUGY
ABPTK
H13
J.N
08R
IQODW
AAORF
ACIEZ
ADOJX
ALYBC
CGR
CUY
CVF
ECM
EIF
NPM
NUSFT
TBQAZ
TDBHL
TERGH
TUROJ
AAYXX
CITATION
7TK
7X8
8BM
ID FETCH-LOGICAL-c465t-cc256bce1c1bd9c8aff3be12fc8a4921d3881b26adcb2ddec69727c035b4908b3
ISSN 0001-6489
IngestDate Fri Aug 16 22:00:19 EDT 2024
Thu Aug 15 22:40:00 EDT 2024
Thu Sep 26 16:23:59 EDT 2024
Sat Sep 28 07:55:06 EDT 2024
Sun Oct 22 16:06:04 EDT 2023
Tue Jul 04 18:13:52 EDT 2023
Thu Feb 29 06:23:55 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Antineoplastic agent
Drug
Hair cell of the ear
Toxicity
Gentamicin
ENT
Antioxidant
Cisplatin
Alkylating agent
Antibiotic
Mitochondria
Aminoglycoside
ROS
Cochlea
Protein synthesis inhibitor
Antibacterial agent
Platinum II Complexes
Apoptosis
Ototoxicity
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c465t-cc256bce1c1bd9c8aff3be12fc8a4921d3881b26adcb2ddec69727c035b4908b3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 19086304
PQID 20952048
PQPubID 23462
PageCount 8
ParticipantIDs proquest_miscellaneous_69877066
informaworld_taylorfrancis_310_1080_00016480701805463
informahealthcare_journals_10_1080_00016480701805463
proquest_miscellaneous_20952048
pubmed_primary_19086304
crossref_primary_10_1080_00016480701805463
pascalfrancis_primary_20597224
PublicationCentury 2000
PublicationDate 2008-01-01
PublicationDateYYYYMMDD 2008-01-01
PublicationDate_xml – month: 01
  year: 2008
  text: 2008-01-01
  day: 01
PublicationDecade 2000
PublicationPlace Stockholm
PublicationPlace_xml – name: Stockholm
– name: England
PublicationTitle Acta oto-laryngologica
PublicationTitleAlternate Acta Otolaryngol
PublicationYear 2008
Publisher Informa UK Ltd
Taylor & Francis
Taylor and Francis
Publisher_xml – name: Informa UK Ltd
– name: Taylor & Francis
– name: Taylor and Francis
References Mukhopadhyay SS (CIT0019) 2006; 175
Pierson MG (CIT0004) 1981; 4
CIT0020
CIT0001
CIT0012
Chae HZ (CIT0009) 1994; 91
Clerici WJ (CIT0003) 1996; 98
Rhee SG (CIT0010) 2001; 52
Rivolta MN (CIT0011) 2002; 53
Zachary AW (CIT0015) 2003; 28
Watnabe K (CIT0017) 2003; 30
Wang J (CIT0018) 2004; 64
Feghali JG (CIT0006) 2001; 111
CIT0014
CIT0002
Evans P (CIT0005) 1999; 884
Teranishi MA (CIT0008) 2003; 67
Rhee SG (CIT0016) 2005; 38
CIT0007
Hoffman DW (CIT0013) 1988; 97
References_xml – volume: 67
  start-page: 133
  year: 2003
  ident: CIT0008
  publication-title: Int J Pediatr Otorhinolaryngol
  doi: 10.1016/S0165-5876(02)00353-1
  contributor:
    fullname: Teranishi MA
– ident: CIT0012
  doi: 10.1006/cbir.1998.0339
– ident: CIT0020
  doi: 10.1074/jbc.M407707200
– volume: 97
  start-page: 36
  year: 1988
  ident: CIT0013
  publication-title: Ann Otol Rhinol Laryngol
  doi: 10.1177/000348948809700107
  contributor:
    fullname: Hoffman DW
– volume: 4
  start-page: 79
  year: 1981
  ident: CIT0004
  publication-title: Hear Res
  doi: 10.1016/0378-5955(81)90037-X
  contributor:
    fullname: Pierson MG
– ident: CIT0007
  doi: 10.1016/S0161-813X(00)00010-3
– volume: 91
  start-page: 7017
  year: 1994
  ident: CIT0009
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.91.15.7017
  contributor:
    fullname: Chae HZ
– ident: CIT0014
  doi: 10.1016/0378-5955(94)90255-0
– volume: 30
  start-page: 219
  year: 2003
  ident: CIT0017
  publication-title: Auris Nasis Larynx
  doi: 10.1016/S0385-8146(03)00049-X
  contributor:
    fullname: Watnabe K
– volume: 884
  start-page: 19
  year: 1999
  ident: CIT0005
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.1999.tb08633.x
  contributor:
    fullname: Evans P
– volume: 52
  start-page: 35
  year: 2001
  ident: CIT0010
  publication-title: IUBMB Life
  doi: 10.1080/15216540252774748
  contributor:
    fullname: Rhee SG
– volume: 53
  start-page: 306
  year: 2002
  ident: CIT0011
  publication-title: J Neurobiol
  doi: 10.1002/neu.10111
  contributor:
    fullname: Rivolta MN
– ident: CIT0001
  doi: 10.1001/archotol.1994.01880290051009
– volume: 38
  start-page: 1543
  year: 2005
  ident: CIT0016
  publication-title: Free Rad Biol Med
  doi: 10.1016/j.freeradbiomed.2005.02.026
  contributor:
    fullname: Rhee SG
– volume: 28
  start-page: 32
  year: 2003
  ident: CIT0015
  publication-title: Trends Biochem Sci
  doi: 10.1016/S0968-0004(02)00003-8
  contributor:
    fullname: Zachary AW
– volume: 175
  start-page: 225
  year: 2006
  ident: CIT0019
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200607061
  contributor:
    fullname: Mukhopadhyay SS
– ident: CIT0002
  doi: 10.3109/08860229309046144
– volume: 98
  start-page: 116
  year: 1996
  ident: CIT0003
  publication-title: Hear Res
  doi: 10.1016/0378-5955(96)00075-5
  contributor:
    fullname: Clerici WJ
– volume: 64
  start-page: 9217
  year: 2004
  ident: CIT0018
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-04-1581
  contributor:
    fullname: Wang J
– volume: 111
  start-page: 1147
  year: 2001
  ident: CIT0006
  publication-title: Laryngoscope
  doi: 10.1097/00005537-200107000-00005
  contributor:
    fullname: Feghali JG
SSID ssj0001985
Score 1.8727425
Snippet Conclusion. Peroxiredoxin (Prx) III plays a protective role in cisplatin- and gentamicin-induced apoptosis via a mitochondria-dependent pathway in cochlear...
Peroxiredoxin (Prx) III plays a protective role in cisplatin- and gentamicin-induced apoptosis via a mitochondria-dependent pathway in cochlear hair cells. The...
CONCLUSIONPeroxiredoxin (Prx) III plays a protective role in cisplatin- and gentamicin-induced apoptosis via a mitochondria-dependent pathway in cochlear hair...
SourceID proquest
crossref
pubmed
pascalfrancis
informaworld
informahealthcare
SourceType Aggregation Database
Index Database
Publisher
StartPage 944
SubjectTerms Anti-Bacterial Agents - pharmacology
Antineoplastic Agents - pharmacology
antioxidant
Apoptosis - drug effects
Apoptosis - physiology
Biological and medical sciences
Cell Culture Techniques
cisplatin
Cisplatin - pharmacology
Cochlea - drug effects
Cochlea - metabolism
Cochlea - pathology
gentamicin
Gentamicins - pharmacology
Hair Cells, Auditory - drug effects
Hair Cells, Auditory - metabolism
Hair Cells, Auditory - pathology
Humans
In Situ Nick-End Labeling
Medical sciences
Mitochondria - drug effects
Mitochondria - metabolism
Mitochondria - pathology
Otorhinolaryngology. Stomatology
ototoxicity
Oxidative Stress - drug effects
Oxidative Stress - physiology
Peroxiredoxin III
Peroxiredoxins - physiology
Reactive Oxygen Species - metabolism
RNA Interference
ROS
Title The role of peroxiredoxin III in the ototoxic drug-induced mitochondrial apoptosis of cochlear hair cells
URI https://www.tandfonline.com/doi/abs/10.1080/00016480701805463
https://www.ncbi.nlm.nih.gov/pubmed/19086304
https://search.proquest.com/docview/20952048
https://search.proquest.com/docview/69877066
Volume 128
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJiFe0LiXy_ADT0SZ6sRJ7MdubLQbaxGsYjxFjhOveSCp2lQq_BP-LceNkyYdGxdVcqPUdhqfz-fm42OE3sSKEaFAcwMACZuKHre5UMImCZUuZSroeXpz8vnIH0zo6aV32en8bEQtLYvoQP747b6S_6Eq3AO66l2y_0DZulO4AddAXyiBwlD-NY2r8ECd8HuV6vSfqzSzhsNhFcGYF_BZpdKK58srG0zwpV7y_wYzGThfFq9P7RCzfFbkJjcJsMipPkzCmop0bmnP_qKpwvZlIXSnNtjE37MrwzxreIytz8fjM-toMK79sWdf-qP31ul4bH3sf9q4VSfaTzaYfLAG-ve6g8nI-jrc1Kw8EmzLI1G6GtZrH-ZwkBYDJrZPy1ODDpKS5_oesYGtkBZTdlgDfbzBYnmZL9JIa142uyYI6shJMAcZsDXCejrx_0bqVSv9W8KwDlF0QO8MQL-5g3adgHtg1-_2D98dntRinnBWHo9h3qhaMteJ27cf21J69kxK3Gkd4LeVJlfH54oFTFFVDt_Nxs9aCbrYQ_eN9YL7JRQfoE6SPUR3z018xiOUAiKxRiTOFW4hEgMiMXwBInGFSNxEJG4hEteI1D1ViMQakXiNyMdocnJ8cTSwzWEetqS-V9hSgnIdyYRIEsVcMqGUGyXEUXBJuUNil4EF5fgilpEDMlf6MPyB7LlepNemI_cJ2snyLHmGMHNdV_qBcoJI0FglUNA4Vl4glIw9KbrobTXa4azM2RKSOhXuFmm6iF6jR2jm-OK2Zl6TZGGxBr0hWOje0m6_Rdv6D1Z466LXFbFD4PR6SEWW5MsF1OCeTrN9cw2fsyAAG6KLnpYo2bw-DKHv9ujzPz3-Bbq3mdIv0U4xXyavQO0uon0zAX4BIRzVZw
link.rule.ids 315,786,790,27957,27958
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+role+of+peroxiredoxin+III+in+the+ototoxic+drug-induced+mitochondrial+apoptosis+of+cochlear+hair+cells&rft.jtitle=Acta+oto-laryngologica&rft.au=HO+SEOK+CHOI&rft.au=KWANG+JOO+PARK&rft.au=SUNG+CHUL+HWANG&rft.au=HUN+YI+PARK&rft.date=2008-01-01&rft.pub=Taylor+and+Francis&rft.issn=0001-6489&rft.eissn=1651-2251&rft.volume=128&rft.issue=9&rft.spage=944&rft.epage=951&rft_id=info:doi/10.1080%2F00016480701805463&rft.externalDBID=n%2Fa&rft.externalDocID=20597224
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-6489&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-6489&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-6489&client=summon